Advanced/Metastatic Clear Cell Renal Cell Carcinoma
2 clinical trials · Condition
◉ Watch Advanced/Metastatic Clear Cell Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC) (NCT06245915) | Arsenal Biosciences, Inc. | 2024-02-26 |
| Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT04696731) | Allogene Therapeutics | 2021-02-24 |
Track Advanced/Metastatic Clear Cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.